Infliximab to Treat Severe Paradoxical Reaction in HIV-Negative Tuberculous Meningoencephalitis

Tuberculous meningoencephalitis was diagnosed in a 33-year-old HIV-negative patient. CSF culture was positive for drug-susceptible Mycobacterium tuberculosis and antituberculous therapy associated with steroids was started. After 3 months, brain MRI showed a worsening of the basal meningeal enhancement and the patient complained of new headaches. CSF analysis demonstrated pleocytosis (100 cells/mm3), with an increased protein count (2,580 mg/dL); CSF culture and viral panel were negative. The worsening was considered due to immune reconstitution inflammatory syndrome and infliximab was started1,2, leading to dramatic clinical and imaging improvement (Figure).

Read article at journal's website

Related Articles

Responses

Your email address will not be published.